Cresilon has raised $25M in a series A funding round. The company is into manufacturing and development of various medical products one of which is a revolutionary hemostatic gel that stops bleeding during a surgical procedure.
Cresilon is led by co-founder & CEO Joe Landolina, and has its headquarters in New York, USA.